Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild-to-moderate Alzheimer's Disease Patients”

Showing 20 of 0 results

Very early researchStudy completedNCT01024660
What this trial is testing

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

Who this might be right for
Alzheimer's Disease
AstraZeneca 155
Early research (Phase 1)Study completedNCT00675090
What this trial is testing

Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 28
Testing effectiveness (Phase 2)Study completedNCT00940589
What this trial is testing

Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor

Who this might be right for
Alzheimer's DiseaseSleep Disorder
Neurim Pharmaceuticals Ltd. 73
Early research (Phase 1)Study completedNCT04715750
What this trial is testing

Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity

Who this might be right for
Alzheimer DiseaseProgressive Supranuclear Palsy
Life Molecular Imaging GmbH 10
Testing effectiveness (Phase 2)Study completedNCT00749216
What this trial is testing

Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 33
Large-scale testing (Phase 3)UnknownNCT01094340
What this trial is testing

Thalidomide for Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Banner Health 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04639050
What this trial is testing

Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 241
Not applicableStudy completedNCT01746498
What this trial is testing

Therapeutic Effect of Direct Current Stimulation on Cognitive Function of Mild to Moderate Alzheimer Patients

Who this might be right for
Alzheimer Disease
Assiut University 33
Early research (Phase 1)Study completedNCT03113812
What this trial is testing

Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Araclon Biotech S.L. 24
Testing effectiveness (Phase 2)Study completedNCT02756858
What this trial is testing

An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Anavex Life Sciences Corp. 21
Early research (Phase 1)Study completedNCT01850238
What this trial is testing

Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Axon Neuroscience SE 30
Not applicableLooking for participantsNCT05295615
What this trial is testing

Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Herrick Medical LLC 40
Large-scale testing (Phase 3)Study completedNCT00423085
What this trial is testing

Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 859
Early research (Phase 1)Study completedNCT01837641
What this trial is testing

LY3002813 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 63
Post-approval studies (Phase 4)UnknownNCT05383183
What this trial is testing

Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Daewoong Bio Inc. 630
Early research (Phase 1)Study completedNCT03019536
What this trial is testing

LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 22
Early research (Phase 1)Study completedNCT01125631
What this trial is testing

Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 8
Large-scale testing (Phase 3)UnknownNCT00314912
What this trial is testing

Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bellus Health Inc. - a GSK company 650
Early research (Phase 1)Study completedNCT02640092
What this trial is testing

Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT00568776
What this trial is testing

ELND005 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
OPKO Health, Inc. 353
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation